beta Casein Blocking Peptide
Référence MBS9631913-1mg
Conditionnement : 1mg
Marque : MyBiosource
Contactez votre distributeur local :
Téléphone : +1 850 650 7790
Beta Casein Blocking Peptide
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9631913MBS9631913 is a blocking peptide targeting CSN2. Also known as beta Casein Blocking Peptide. More details
Product Overview
Online Datasheet in PDFProduct Name
beta Casein (CSN2), Blocking Peptide
Full Product Name
beta Casein Blocking Peptide
Product Gene Name
CSN2 blocking peptide
Product Synonym Names
Beta-casein; CASB; CASB_HUMAN; Casein beta; CSN 2; Csn2
Antibody/Peptide Pairs
CSN2 peptide (MBS9631913) is used for blocking the activity of CSN2 antibody (MBS9629530)
Molecular Weight
25,382 Da
OMIM
115460
Supply Chain Verification
Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of CSN2 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for CSN2. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
beta-casein isoform 1
NCBI Official Synonym Full Names
casein beta
NCBI Official Symbol
CSN2
NCBI Official Synonym Symbols
CASB
UniProt Protein Name
Beta-casein
Protein Family
Beta-casein
UniProt Gene Name
CSN2
UniProt Synonym Gene Names
CASB
UniProt Entry Name
CASB_HUMAN
NCBI Protein Information
beta-casein
NCBI Summary for CSN2
This gene is a member of the beta casein family. There are two types of casein protein, beta (encoded by this gene) and kappa, both of which are secreted in human milk. Beta casein is the principal protein in human milk and the primary source of essential amino acids for a suckling infant. Beta and kappa casein proteins acting together form spherical micelles which bind within them important dietary minerals, such as calcium and phosphorous. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Show more UniProt Comments for CSN2
CSN2: Important role in determination of the surface properties of the casein micelles. Belongs to the beta-casein family.
Protein type: Secreted; Calcium-binding; Inhibitor; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 4q21.1
Cellular Component: extracellular space; extracellular region
Molecular Function: enzyme inhibitor activity; transporter activity; calcium ion binding
Biological Process: lactation; calcium ion transport; negative regulation of catalytic activity
Show more Protein type: Secreted; Calcium-binding; Inhibitor; Secreted, signal peptide
Chromosomal Location of Human Ortholog: 4q21.1
Cellular Component: extracellular space; extracellular region
Molecular Function: enzyme inhibitor activity; transporter activity; calcium ion binding
Biological Process: lactation; calcium ion transport; negative regulation of catalytic activity
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with CSN2 blocking peptide
| Reference Product | PubMed Publications |
|---|---|
| CSN3 blocking peptide | >46 publications with CSN2 and CSN3 |
| CSN1S1 blocking peptide | >38 publications with CSN2 and CSN1S1 |
| LALBA blocking peptide | >13 publications with CSN2 and LALBA |
| IGF2 blocking peptide | >1 publications with CSN2 and IGF2 |
| STAT3 blocking peptide | >1 publications with CSN2 and STAT3 |
| COPS5 blocking peptide | >1 publications with CSN2 and COPS5 |
Pathways associated with CSN2 blocking peptide
| Products by Pathway | Pathway Diagram |
|---|---|
| Glucocorticoid Receptor Regulatory Network Pathway antibodies | Glucocorticoid Receptor Regulatory Network Pathway Diagram |
| Nuclear Signaling By ERBB4 Pathway antibodies | Nuclear Signaling By ERBB4 Pathway Diagram |
| Prolactin Signaling Pathway antibodies | Prolactin Signaling Pathway Diagram |
| Prolactin Signaling Pathway antibodies | Prolactin Signaling Pathway Diagram |
| Signal Transduction Pathway antibodies | Signal Transduction Pathway Diagram |
| Signaling By ERBB4 Pathway antibodies | Signaling By ERBB4 Pathway Diagram |
| Signaling Events Mediated By PTP1B Pathway antibodies | Signaling Events Mediated By PTP1B Pathway Diagram |
Diseases associated with CSN2 blocking peptide
| Disease Name | Pubmed Publications |
|---|---|
| Carcinoma Antibodies | >5 publications with CSN2 and Carcinoma |
| Cardiovascular Diseases Antibodies | >2 publications with CSN2 and Cardiovascular Diseases |
| Breast Neoplasms Antibodies | >2 publications with CSN2 and Breast Neoplasms |
| Inflammation Antibodies | >2 publications with CSN2 and Inflammation |
| Nervous System Malformations Antibodies | >2 publications with CSN2 and Nervous System Malformations |
| Atherosclerosis Antibodies | >1 publications with CSN2 and Atherosclerosis |
| Necrosis Antibodies | >1 publications with CSN2 and Necrosis |
| Kidney Diseases Antibodies | >1 publications with CSN2 and Kidney Diseases |
| Prenatal Injuries Antibodies | >1 publications with CSN2 and Prenatal Injuries |
| Prenatal Exposure Delayed Effects Antibodies | >1 publications with CSN2 and Prenatal Exposure Delayed Effects |